Scott Kelley

Currently holds a position at Flexion Therapeutics Inc

Position	Company	Period
Chief Medical Officer	Flexion Therapeutics Inc	Dec. 11, 2017 -
Vice President - Medical Affairs	Flexion Therapeutics Inc	March 9, 2017 - Dec. 11, 2017

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2021-01-07	2021-01-05	Flexion Therapeutics Inc (FLXN)	PlS Planned sale	55,177 -37.8% 381.35 US$4,142,990	55,177 -37.8%	381.35	US$4,142,990
2020-01-07	2020-01-03	Flexion Therapeutics Inc (FLXN)	S Sale	96,421 118.58 US$1,993,993	96,421	118.58	US$1,993,993
2019-01-04	2019-01-03	Flexion Therapeutics Inc (FLXN)	PlS Planned sale	66,560 -42.1% 188.94 US$2,541,345	66,560 -42.1%	188.94	US$2,541,345